n-(3-pyridylmethyl)adriamycin has been researched along with serine in 1 studies
Studies (n-(3-pyridylmethyl)adriamycin) | Trials (n-(3-pyridylmethyl)adriamycin) | Recent Studies (post-2010) (n-(3-pyridylmethyl)adriamycin) | Studies (serine) | Trials (serine) | Recent Studies (post-2010) (serine) |
---|---|---|---|---|---|
17 | 0 | 13 | 23,914 | 115 | 6,084 |
Protein | Taxonomy | n-(3-pyridylmethyl)adriamycin (IC50) | serine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.015 | |
Cholinesterase | Equus caballus (horse) | 0.016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Charan Raja, MR; Harish, BS; Jayaraman, A; Kar Mahapatra, S; Kar, A; Srinivasan, S; Uppuluri, KB | 1 |
1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and serine
Article | Year |
---|---|
Oceanimonas sp. BPMS22-derived protein protease inhibitor induces anti-leishmanial immune responses through macrophage M2 to M1 repolarization.
Topics: Animals; Arginase; Cytokines; Immunity; Interleukin-12; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Nitric Oxide; Protease Inhibitors; RNA, Messenger; Serine; Tandem Mass Spectrometry; Trypsin | 2022 |